Methylation profiling

Dataset Information

0

ELOVL2 is a novel tumor suppressor attenuating tamoxifen resistance in breast cancer via suppressing the AKT pathway [methylation 850K]

ABSTRACT: Genome wide DNA methylation profiling of tamoxifen-resistant(Tam-R) breast cancer cell line MCF-7. The Illumina Infinium MethylationEPIC BeadChip was used to obtain DNA methylation profiles across approximately 850,000 CpGs.

ORGANISM(S): Homo sapiens

PROVIDER: GSE132616 | GEO | 2020/06/12

REPOSITORIES: GEO

Json Xml

Similar Datasets

Methylation profiling ELOVL2 is a novel tumor suppressor attenuating tamoxifen resistance in breast cancer via suppressing the AKT pathway [methylation 450K]
2020-06-12 | GSE132615 | GEO
Transcriptomics ELOVL2 is a novel tumor suppressor attenuating tamoxifen resistance in breast cancer via suppressing the AKT pathway
2020-06-12 | GSE132617 | GEO
Transcriptomics ELOVL2 is a novel tumor suppressor attenuating tamoxifen resistance in breast cancer via suppressing the AKT pathway [gene expression]
2020-06-12 | GSE132614 | GEO
Genomics ELOVL2 is a novel tumor suppressor attenuating tamoxifen resistance in breast cancer via suppressing the AKT pathway [methylation 850K]
| PRJNA548634 | ENA
Unknown ELOVL2: a novel tumor suppressor attenuating tamoxifen resistance in breast cancer.
| S-EPMC8263635 | biostudies-literature
Transcriptomics Methylation profiling of the aging epidermis [850k]
2020-07-24 | E-MTAB-8993 | biostudies-arrayexpress
Genomics Whole transcriptome and 850k methylome profiling of human MBM
| EGAD00010002281 | EGA
Genomics ELOVL2 is a novel tumor suppressor attenuating tamoxifen resistance in breast cancer via suppressing the AKT pathway [methylation 450K]
| PRJNA548633 | ENA
Methylation profiling Genome wide methylation analysis of 16 melanoma cell lines
2018-08-31 | GSE114721 | GEO
Methylation profiling DNA methylation of diabetic and normal human limbal epithelial cells
2023-04-15 | GSE229328 | GEO